[Federal Register: July 27, 2005 (Volume 70, Number 143)]
[Notices]
[Page 43456]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27jy05-121]
[[Page 43456]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated February 23, 2005 and published in the Federal
Register on March 4, 2005, (70 FR 10680-10681), Lipomed Inc., One
Broadway, Cambridge, Massachusetts 02142, made application by renewal
to the Drug Enforcement Administration (DEA) to be registered as an
importer of the basic classes of controlled substances listed in
Schedules I and II.
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)........................... I
Methaqualone (2565)........................ I
Gamma-Hydroxybutyric Acid (2010)........... I
Lysergic acid diethylamide (7315).......... I
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
3,4,5-Trimethoxyamphetamine (7390)......... I
4-Bromo-2-5-dimethoxyamphetamine (7391).... I
4-Methyl-2,5-dimethoxyamphetamine (7395)... I
2,5-Dimethoxyamphetamine (7396)............ I
2,5-Dimethoxy-4-ethylamphetamine (7399).... I
3,4-Methylenedioxyamphetamine (7400)....... I
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxymethamphetamine (7405)... I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
Acetyldihydrocodeine (9051)................ I
Dihydromorphine (9145)..................... I
Heroin (9200).............................. I
Tilidine (9750)............................ I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Amobarbital (2125)......................... II
Secobarbital (2315)........................ II
Phencyclidine (7471)....................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Benzoylecgonine (9180)..................... II
Hydrocodone (9193)......................... II
Levorphanol (9220)......................... II
Methadone (9250)........................... II
Dextropropoxphene (9273)................... II
Morphine (9300)............................ II
Thebaine (9333)............................ II
Oxymorphone (9652)......................... II
Alfentanil (9737).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to import small reference standard quantities of
finished commercial product from its sister company in Switzerland for
distribution to its customers for drug testing and pharmaceutical
research and development.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Lipomed Inc. to import the basic classes of controlled
substances is consistent with the public interest and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has investigated
Lipomed Inc. to ensure that the company's registration is consistent
with the public interest. The investigation has included inspection and
testing of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above
named company is granted registration as an importer of the basic
classes of controlled substances listed.
Dated: July 19, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-14832 Filed 7-26-05; 8:45 am]
BILLING CODE 4410-09-P